Cost-Effectiveness of Adalimumab for Rheumatoid Arthritis in Germany.

被引：0
|
作者：
Gissel, Christian [1 ]
Goetz, Georg [1 ]
Repp, Holger [1 ]
Lange, Uwe [2 ]
机构：
[1] Univ Giessen, D-35390 Giessen, Germany
[2] Univ Giessen, Kerckhoff Clin, Bad Nauheim, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2014年 / 66卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1146
引用
收藏
页码：S503 / S503
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany
    Gissel, C.
    Goetz, G.
    Repp, H.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2016, 75 (10): : 1006 - 1015
  • [2] COST-EFFECTIVENESS OF ADALIMUMAB FOR RHEUMATOID ARTHRITIS IN GERMANY
    Gissel, C.
    [J]. VALUE IN HEALTH, 2014, 17 (03) : A48 - A48
  • [3] Cost-effectiveness of adalimumab for rheumatoid arthritis in Germany; [Kosten-Nutzen-Bewertung von Adalimumab bei Rheumatoider Arthritis in Deutschland]
    Gissel C.
    Götz G.
    Repp H.
    [J]. Zeitschrift für Rheumatologie, 2016, 75 (10) : 1006 - 1015
  • [4] Need for improvements in reported cost-effectiveness of adalimumab in rheumatoid arthritis
    Gissel, C.
    Goetz, G.
    Repp, H.
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2017, 76 (02): : 185 - 185
  • [5] THE COST-EFFECTIVENESS OF ADALIMUMAB (HUMIRA™) IN PATIENTS WITH RHEUMATOID ARTHRITIS: A UK ANALYSIS
    Bansback, N.
    Brennan, A.
    Sengupta, N.
    Pang, F.
    [J]. RHEUMATOLOGY, 2004, 43 : 77 - 77
  • [6] The cost-effectiveness of adalimumab (HUMIRA®) in patients with rheumatoid arthritis (RA) in Denmark
    Aagren, M.
    Davies, A.
    Winding, B.
    Cifaldi, M.
    Pang, F.
    [J]. SCANDINAVIAN JOURNAL OF RHEUMATOLOGY, 2006, 35 : 15 - 15
  • [7] COST-EFFECTIVENESS ANALYSIS OF ADALIMUMAB BIOSIMILAR COMPARED TO DELAYED BIOLOGIC TREATMENT INITIATION IN PATIENTS WITH RHEUMATOID ARTHRITIS IN GERMANY
    Porter, J.
    Stuart, P.
    Bartsch, R.
    Lebioda, A.
    [J]. VALUE IN HEALTH, 2021, 24 : S15 - S15
  • [8] Cost-Effectiveness Analysis of Biopharmaceuticals for Treating Rheumatoid Arthritis: Infliximab, Adalimumab, and Etanercept
    Gholami, Ahmad
    Azizpoor, Jassem
    Aflaki, Elham
    Rezaee, Mehdi
    Keshavarz, Khosro
    [J]. BIOMED RESEARCH INTERNATIONAL, 2021, 2021
  • [9] COST-EFFECTIVENESS OF RITUXIMAB VS ADALIMUMAB IN THE TREATMENT OF MODERATE TO SEVERE RHEUMATOID ARTHRITIS
    Bynum, L. A.
    Joshi, N.
    [J]. VALUE IN HEALTH, 2010, 13 (03) : A126 - A126
  • [10] Cost-effectiveness of adalimumab (Humira™) in the treatment of US patients with rheumatoid arthritis (RA)
    Bansback, N
    Brennan, A
    Sengupta, N
    [J]. VALUE IN HEALTH, 2004, 7 (03) : 241 - 241
12345